- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02612987
iCBT for Adolescents With Co-morbid Insomnia
March 2, 2018 updated by: Vendela Zetterqvist, Uppsala University Hospital
Internet-delivered Cognitive Behaviour Therapy for Adolescents With Co-morbid Insomnia Attending Children and Youth Psychiatry: An Open Trial
Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions.
It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load.
Treatment of insomnia has been extensively examined in adults, but studies with adolescents are sparse.
The purpose of this pilot study is to assess the feasibility and efficacy of internet-based cognitive behavioral therapy for insomnia (iCBT) in outpatients of Children and Youth Psychiatry.
Twenty-one adolescents will be recruited and receive 7 weeks of iCBT.
Outcome will be measured at pre treatment, at post treatment and at a three months follow-up.
Weekly assessments will also be made during treatment on primary outcome and a presumed process variable constructed for the purpose of this trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Uppsala Län
-
Uppsala, Uppsala Län, Sweden, 751 85
- Uppsala University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- To fulfill the diagnostic criteria for insomnia
- To have access to a computer with Internet connection
- No previous or ongoing CBT for insomnia
- No psychotropic medication or being on a stable dosage for at least six weeks before enrollment
Exclusion Criteria:
- Ongoing manic or psychotic episode
- Being at high risk of triggering manic or psychotic episode
- Ongoing sleep apnea
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: iCBT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia Severity Index (ISI; Morin, 1993)
Time Frame: Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
Given that this is an intervention study we are assessing changes in outcome over time.
|
Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Core Consensus Sleep Diary (Core CSD; Carney et al., 2012)
Time Frame: Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
Given that this is an intervention study we are assessing changes in outcome over time.
|
Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
|
Symptoms Checklist (SCL-90; Derogatis et al., 1994)
Time Frame: Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
Given that this is an intervention study we are assessing changes in outcome over time.
|
Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
|
Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S; Svanborg & Åsberg, 1994)
Time Frame: Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
Given that this is an intervention study we are assessing changes in outcome over time.
|
Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Vendela Zetterqvist, Ph D, Uppsala University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
October 1, 2017
Study Registration Dates
First Submitted
November 15, 2015
First Submitted That Met QC Criteria
November 19, 2015
First Posted (Estimate)
November 24, 2015
Study Record Updates
Last Update Posted (Actual)
March 5, 2018
Last Update Submitted That Met QC Criteria
March 2, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015/326
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyssomnias
-
Eisai Inc.RecruitingNarcolepsySpain, United States, Belgium, Germany, Italy, Switzerland, China, South Korea, Canada, Japan
-
Suven Life Sciences LimitedNot yet recruiting
-
Universidad Autonoma de Baja CaliforniaNot yet recruiting
-
Clinique Beau SoleilNot yet recruiting
-
BELL Therapeutics Inc.Not yet recruitingInsomnia | Sleep Initiation and Maintenance DisordersSouth Korea
-
Beijing Sport UniversityNot yet recruiting
-
Beijing Tiantan HospitalInner Mongolia Autonomous Region Mental Health CenterNot yet recruiting
-
Sunshine Lake Pharma Co., Ltd.Completed
-
University of PrimorskaBiostile d.o.o.Active, not recruiting
-
H. Lundbeck A/SRecruiting
Clinical Trials on Internet-based Cognitive Behaviour Therapy (iCBT)
-
Uppsala University HospitalUppsala University; Karolinska UniversityCompleted
-
Karolinska InstitutetVastra Gotaland Region; Region Skane; Region StockholmRecruitingBody Dysmorphic DisordersSweden
-
Karolinska InstitutetRegion StockholmActive, not recruiting
-
Örebro County CouncilKarolinska InstitutetCompleted
-
Karolinska InstitutetDeakin UniversityRecruiting
-
Centre for Addiction and Mental HealthCompletedGeneralized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic DisorderCanada
-
Stockholm UniversityCompletedProcrastinationSweden
-
Linkoeping UniversityRecruiting
-
Jouf UniversityCompletedPregnant Women | Self Efficacy | Fear of Childbirth | Cognitive Behavioral TherapyEgypt
-
Linkoeping UniversityActive, not recruitingAnxiety Symptoms | Depression SymptomsSweden